Mr. Chair, it would be difficult for me to answer questions about approval of drugs, two different substances, without really talking to those who actually approve the drugs, or devices, if that is what the hon. member is talking about.
I would suggest to the hon. member that she remain in touch with my office. I would be happy to talk to her and tell her when we can expect to have that done.